
Mystified by the human brain? This doctor has spent years observing it
Doctors' accounts of their lives and work have historically tended towards the megalomaniacal. This is true not only of those dealing with matters of life and death both daily and viscerally (emergency doctors; surgeons), but also of those who are used to holding dominion over the brain. I've read more than a few medical memoirs that betray no uncertainty, reveal no insecurity, offer no hesitation or deviation from the wearying doxa that nothing bar rocket science could compare to the complexity and prestige of studying the brain.
The Mind Electric, Pria Anand's first book, is nothing like these. It brings together into one compelling volume autobiography, clinical anecdotes, family lore, medical history, medical mystery and an appropriate dose of politics – for Anand works at what is known in the American system as a 'safety-net hospital', and continually confronts the consequences of her country's paltry yet blisteringly expensive approach to public healthcare.
Because neurology continually moves between the brain and the mind, between the manifest and the unseen, and between what patients feel and doctors think, it's impossible, in general, to fully disentangle it from the practice and history of psychiatry, nor the violence which punctuates that murky past. Anand doesn't flinch in confronting this legacy or its continued grip on medical discourse. She describes, for instance, how the specific terminology that doctors use – the patient 'complains'; the patient 'denies' – imbues the clinical encounter with needless adversity.
Anand writes with circumspection and sensitivity, and with creativity and verve as well. Despite her abiding interest in narrative coherence, the book itself is delightfully labyrinthine; Anand refuses linearity, much less chronological order, and instead offers a strange and compelling tapestry of stories somehow both discrete and happening all at once, its threads overlapping and interweaving with layers hidden underneath.
She takes readers from ancient Egypt, through the Salpêtrière (France's brutal 17th-century women's hospice), and right into the consulting rooms of today. With no need for exaggeration or polemic, she brings into especially sharp relief how neurology has enacted the mistreatment of women's health for as long as men have been messing about with our nerves. In a particularly jarring example, she explains that not only do women suffer from multiple sclerosis three times as frequently as men, but they're still also frequently disbelieved, being dismissed as 'hysterical' by doctors repeatedly before finally being diagnosed.
Amid all this, Anand unabashedly braids in intimate and exposing personal details. She discloses private tragedies, moral injuries, mistakes; these are the pieces that make this memoir genuinely compelling. Several times, Anand calls her medical training 'alchemical', making clear that what might be mythologised as an impossible power really offers a Midas touch, its initiants being possessed of intimate knowledge of human life while being required to detach from, or even deny, their own humanity.
At one point, she describes being plagued for months by overwhelming aural symptoms – the persistent, resonant, throbbing sound of her own pulse, accompanied by debilitating disorientation – while being equally stubbornly attached to an imaginary bright line between sick people and doctors. She writes of her 'refusal to acknowledge my physical frailty welling from some primal desire to separate myself from my patients, to imagine that I was in some elemental way apart from the suffering that surrounded me [and] somehow inoculated against it'.
Such insights not only show the thoughtfulness with which Anand reflects upon her profession: they also underscore the project of The Mind Electric, which is – at least in part – to move us beyond the limits of our prior knowledge. She wants us to imagine new, less precise and less totalising narratives about the mind, medicine and power; she invites us to think again about what happens at all of life's edges and in-betweens. For Anand, those projects are inescapably literary, born of her abiding love of fables and tales of magic, her enduring enchantment with folklore and the fantastic. It's plain to see that her imagination, in turn, underpins her skill as a physician. As this superb book shows, the human impulse to gather information, to put things into order – then speak, be understood and be believed – controls quite possibly every aspect of our lives.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE I was told by TWO hospitals that I had gallstones when I actually had stage four cancer... now I won't get to see my little girl grow up
A mother whose gallstones turned out to be stage-four cancer has blasted doctors for waiting five months to test a mass on her pancreas. When Kanisha Collins, 24, was diagnosed with pancreatitis at Royal Chesterfield Hospital in December, she didn't think to question their expert judgment. After all, they were in close contact with a team of specialists over at Weston Park Hospital in Sheffield, one of just four dedicated cancer centres in the UK. And the coalition of doctors persistently stuck to its guns, even after a second CT scan in February showed a persistent mass on her pancreas and a worsening blood clot. But then the pain got worse. Rushed to hospital just weeks after being told the mass was 'benign', Kanisha, who has a two-year-old daughter, was hit with the discovery of lesions on her liver and the news that staff would finally be performing a biopsy. On May 19, she was diagnosed with stage-four pancreatic cancer which had spread to the liver, after months of doctors insisting she was too young to be struck with the illness. A day after starting chemotherapy at Weston Park, Kanisha, whose father Dean has raised more than £4,000 for her family on GoFundMe, told MailOnline she blamed specialists at both hospitals for acting too slowly to spot her, now incurable, cancer. She told MailOnline: 'This was all because they wouldn't test the mass on my pancreas, because they didn't think somebody my age would have pancreatic cancer. 'I've been failed by both hospitals in a way, but I feel like my consultant could have done more at the time. 'The reason they didn't was because of my age. Unfortunately, when they told me [I had cancer] it was too late and incurable. 'Absolutely [I feel let down]. Cancer [diagnoses] should never [be based] off somebody's age. 'It should always be tested, no matter what, no matter how old you are, it should be tested from the get go and not left because they think you're too young. 'I felt discriminated against because I was so young. My kind of cancer is actually genetic and my daughter has to be tested down the line.' Before her diagnosis, Kanisha's life had been gathering pace. Her daughter Amaya had just turned two and she was about to get married to her partner Mason. The wedding had long been in the diary for this Saturday, but no one could ever have anticipated it would fall at the end of her first week of chemotherapy. 'I feel heartbroken, because obviously I have a two-year-old daughter at home,' she said. 'I get married on Saturday and I had all that to look forward to in the future. 'But that's been cut short unfortunately.' Sitting by her side during her first night of chemo, her father Dean chimed in: 'They're getting married on Saturday, which was planned last year, but cancer wasn't planned. 'The idea is, once they've got married, to go to the sit down meal. Then once we've done that, I'll take her back home so she can have a rest before coming back to spend a bit of time with the evening guests. 'She's going to have a break in between all that to recharge her batteries.' Kanisha's chemotherapy battle is in its early days, but her stoicism in the wake of her life being turned upside down has taken even her parents by surprise. 'Before all this, I was a fit and healthy person and now I can barely do day-to-day walking tasks, because I just get out of breath,' she said. 'I'm on chemo, I'm tired, so it's hard, but I suppose I've got to look for the positive side, that the chemo will shrink enough to give me many years down the line. 'We're all staying positive about it and hoping that treatment will shrink my tumours enough to give me a few years.' Her father added: 'She actually seems stronger than both me and her mum. She's got to be strong for herself and for her daughter and partner.' Dean reacted to Kanisha's diagnosis by setting up a Gofundme, drawing on his experience looking after his sister, who died with cancer, as well as the writing skills of his older daughter's boyfriend, to create an already-flying donation page. The fundraiser earned £4,000 in its first 24 hours, receiving more than 150 donations. Its aims are two-fold: to give Kanisha the opportunity to enjoy what time she has left with her daughter, and to help her soon-to-be husband in the tough times ahead. The Gofundme's soaring success has been a rare source of positivity for the mother, following an incredibly difficult five months. She said: 'It's just to give myself and my family a good holiday and to make those lasting memories. And to not have to worry about the financial side of things, so we can do things as a family. 'At the moment, unfortunately, I'm not able to fly due to the fact I'm on intense chemotherapy, but my main goal is a nice family holiday down in Cornwall. It's always been my favourite place to go since being a little girl. 'And just being able to show my daughter the other parts of England that I've been able to see. 'Eventually after my chemo, if it is successful, I would like to take her on that family holiday abroad, if it is possible. That's my main goal. 'It's for my daughter's future as well, just so I know she's going to have a good life.' Dean added: 'The frustrating thing about it is [the delay in diagnosis]. It was a catalogue of errors between the two hospitals. That's how it seems to me. 'One set not talking to the other and then the other people just don't seem to be wanting to to push it further forward, to do further tests, purely because she was young. 'So my aim now is to bring further awareness out there, with regards to cancer, because there's loads of people out there who have experienced it.' Dr Hal Spencer, Chief Executive of Chesterfield Royal Hospital said: 'We always strive to give the best care, and we are sorry to hear of Kanisha's experience. 'Throughout, her care has always been considered seriously, and we have consulted with regional specialist colleagues who were advising us on her care and management. 'We would encourage Kanisha and her family to contact us, and we will support them in a full review of her care in order that we can understand the decisions taken and the management advice given. 'This will help inform our internal reviews already underway.' here.


Reuters
an hour ago
- Reuters
US COVID vaccine recommendations sow confusion among doctors, insurers
CHICAGO, June 5 (Reuters) - Health Secretary Robert F. Kennedy Jr.'s intervention in COVID-19 vaccine recommendations without input from a key U.S. CDC advisory panel has sown confusion among physicians and insurers over who should get the shots and whether they will be covered, experts told Reuters. Kennedy, a long-time vaccine skeptic, in a video posted on social media last week said the government was dropping its recommendation that healthy children and pregnant women should receive COVID shots. Days later, the Centers for Disease Control and Prevention updated its recommended childhood vaccine schedule online to show the shots could be given to healthy children when parents and doctors agree they are needed. It removed its recommendation that pregnant women should receive the shot. The moves sidestepped the normal process in which a panel of outside experts to the CDC - the Advisory Committee on Immunization Practices - reviews data in a public meeting and votes on vaccine recommendations. The ACIP recommendations are sent to the CDC director for approval and incorporated in the agency's vaccine schedule, which helps determine insurance coverage under the Affordable Care Act. "The surprise announcement has created uncertainty for payers and providers about whether the video posting constitutes an official policy change," said Sarah Moselle, a principal at health consultancy Avalere. Insurers will wait to make coverage decisions until after ACIP makes a recommendation at its upcoming meeting scheduled for June 25-27, according to Robert Popovian, founder of healthcare consultancy Conquest Advisors. The Department of Health and Human Services overseen by Kennedy said the move was within its legal and regulatory authority and reflects the agency's move toward clinical-guided decision making, a department spokesperson said. HHS will continue to rely on the work of expert panels, including ACIP, he said, noting that the committee will be meeting this month. The meeting agenda will be released in accordance with prior practice. Determinations on coverage are up to insurance providers, the spokesperson said. The CDC has previously recommended the COVID shot for everyone aged 6 months and older. "This whole thing is so murky," said an ACIP member who spoke on condition of anonymity. "It's very unclear whose decision is final." Infectious Diseases Society of America President Dr. Tina Tan said the conflicting COVID vaccine guidance could cause "significant confusion among medical professionals and the public." Dr. Matthew Zahn, an Orange County, California, public health official at OC Health Care Agency who serves as a liaison to the CDC's advisory panel, said: "We're all awaiting clarity." "It's going to be important to understand how these vaccines are insured," Zahn said. "Specifically, if ultimately there is a recommendation for high-risk populations to be vaccinated, how that is interpreted by insurance companies and thus, how providers can recommend it." Zahn expects CDC to clarify its guidance in the weeks ahead, though he could not comment on whether that will be at the ACIP meeting. On Tuesday, Reuters reported that pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos, a CDC official who helped oversee the expert panel on COVID vaccines, told colleagues she was leaving her post as she was "no longer able to help the most vulnerable members" of the U.S. population. The American College of Obstetricians and Gynecologists raised concerns on May 27 that the HHS decision not to recommend COVID vaccines during pregnancy would make it harder for pregnant women to get the shot "despite the clear and definitive evidence demonstrating its benefit." The Affordable Care Act generally requires insurers to cover vaccines that are listed on ACIP's vaccine schedule, according to the CDC's website. Narrowing coverage without knowing what ACIP recommends could put insurers at risk, Popovian said. "It's a liability," he said, adding that insurers need clarity on what they will be required to cover. A source familiar with plans for the meeting said the panel is expected to consider and vote on COVID-19 vaccines for the upcoming autumn and winter season, adding that the panel had been leaning toward narrowing its recommendations. The advisory panel has yet to receive an agenda for the upcoming meeting, the source said, and it is unclear whether Kennedy would override any deviation from his announced policy.


The Independent
an hour ago
- The Independent
Who's in charge? CDC's leadership 'crisis' apparent amid new COVID-19 vaccine guidance
There was a notable absence last week when U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced in a 58-second video that the government would no longer endorse the COVID-19 vaccine for healthy children or pregnant women. The director of the Centers for Disease Control and Prevention — the person who typically signs off on federal vaccine recommendations — was nowhere to be seen. The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for budding threats to Americans' health, is without a clear leader. 'I've been disappointed that we haven't had an aggressive director since — February, March, April, May — fighting for the resources that CDC needs,' said Dr. Robert Redfield, who served as CDC director under the first Trump administration and supported Kennedy's nomination as the nation's health secretary. $9.2 billion-a-year agency without leader as nomination awaits The leadership vacuum at a foremost federal public health agency has existed for months, after President Donald Trump suddenly withdrew his first pick for CDC director in March. A hearing for his new nominee — the agency's former acting director Susan Monarez — has not been scheduled because she has not submitted all the paperwork necessary to proceed, according to a spokesman for Sen. Bill Cassidy, R-La., who will oversee the nomination. HHS did not answer written questions about Monarez's nomination, her current role at the CDC or her salary. An employee directory lists Monarez, a longtime government employee, as a staffer for the NIH under the Advanced Research Projects Agency for Health. Redfield described Kennedy as 'very supportive' of Monarez's nomination. Instead, a lawyer and political appointee with no medical experience is 'carrying out some of the duties' of director at the agency that for seven decades has been led by someone with a medical degree. Matthew Buzzelli, who is also the chief of staff at the CDC, is 'surrounded by highly qualified medical professionals and advisors to help fulfill these duties as appropriate,' Andrew Nixon, an HHS spokesperson said in a statement. Adding to the confusion was an employee-wide email sent last week that thanked 'new acting directors who shave stepped up to the plate." The email, signed by Monarez, listed her as the acting director. It was was sent just days after Kennedy said at a Senate hearing that Monarez had been replaced by Buzzelli. The lack of a confirmed director will be a problem if a public health emergency such as the COVID-19 pandemic or a rapid uptick in measles cases hits, said Michael Osterholm, an epidemiologist at the University of Minnesota. 'CDC is a crisis, waiting for a crisis to happen,' said Osterholm. 'At this point, I couldn't tell you for the life of me who was going to pull what trigger in a crisis situation." An acting director rarely seen, and stalled decisions At CDC headquarters in Atlanta, employees say Monarez was rarely heard from between late January – when she was appointed acting director – and late March, when Trump nominated her. She also has not held any of the 'all hands' meetings that were customary under previous CDC chiefs, according to several staffers. One employee, who insisted on anonymity because they were not authorized to speak to the media and fears being fired if identified said Monarez has been almost invisible since her nomination, adding that her absence has been cited by other leaders as an excuse for delaying action. The situation already has led to confusion. In April, a 15-member CDC advisory panel of outside experts met to discuss vaccine policy. The panel makes recommendations to the CDC Director, who routinely signs off on them. But it was unclear during the meeting who would be reviewing the panel's recommendations, which included the expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. HHS officials said the recommendations were going to Buzzelli, but then weeks passed with no decision. A month after the meeting ended, the CDC posted on a web site that Kennedy had signed off on recommendations for travelers against chikungunya, a viral disease transmitted to humans by mosquitos. But there continues to be no word about a decision about the other vaccine recommendations. Controversial COVID-19 vaccine recommendations bypassed CDC panel The problem was accentuated again last week, when Kennedy rolled out recommendations for the COVID-19 vaccine saying they were no longer recommended for healthy children or pregnant women, even though expectant mothers are considered a high-risk group if they contract the virus. Kennedy made the surprise announcement without input from the CDC advisory panel that has historically made recommendations on the nation's vaccine schedule. The CDC days later posted revised guidance that said healthy kids and pregnant women may get the shots. Nixon, the HHS spokesman, said CDC staff were consulted on the recommendations, but would not provide staffer's names or titles. He also did not provide the specific data or research that Kennedy reviewed to reach his conclusion on the new COVID-19 recommendations, just weeks after he said that he did not think 'people should be taking medical advice' from him. 'As Secretary Kennedy said, there is a clear lack of data to support the repeat booster strategy in children,' Nixon said in a statement. Research shows that pregnant women are at higher risk of severe illness, mechanical ventilation and death, when they contract COVID-19 infections. During the height of the pandemic, deaths of women during pregnancy or shortly after childbirth soared to their highest level in 50 years. Vaccinations also have been recommended for pregnant women because it passes immunity to newborns who are too young for vaccines and also vulnerable to infections. Nixon did not address a written question about recommendations for pregnant women. Kennedy's decision to bypass the the advisory panel and announce new COVID-19 recommendations on his own prompted a key CDC official who works with the committee – Dr. Lakshmi Panagiotakopoulos – to announce her resignation last Friday. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in an email seen by an Associated Press reporter. Signs are mounting that the CDC has been 'sidelined' from key decision-making under Kennedy's watch, said Dr. Anand Parekh, the chief medical adviser for The Bipartisan Policy Center. 'It's difficult to ascertain how we will reverse the chronic disease epidemic or be prepared for myriad public health emergencies without a strong CDC and visible, empowered director,' Parekh said. 'It's also worth noting that every community in the country is served by a local or state public health department that depends on the scientific expertise of the CDC and the leadership of the CDC director.'